Amoéba has received marketing authorization in France for its biofungicide AXPERA

Chassieu, July 01, 2026 (GLOBE NEWSWIRE) — Amoéba (FR0011051598 – ALMIB), industrial greentech specialized in the development of natural microbiological solutions, announces that it has obtained marketing authorization for its biofungicide AXPERA in France. This first authorisation, granted by ANSES following the evaluation conducted by France in its capacity as rapporteur Member State for European […]